Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Tatsuya Itoh"'
Autor:
Shota Kadomura, Yoh Takekuma, Yuki Sato, Masato Sumi, Kotaro Kawamoto, Tatsuya Itoh, Mitsuru Sugawara
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 5, Iss 1, Pp 1-8 (2019)
Abstract Background Piperacillin/tazobactam (PIPC/TAZ) and cefepime (CFPM) are commonly used for the treatment of nosocomial and healthcare-associated infections. Recent reports have suggested that the incidence of acute kidney injury (AKI) in patien
Externí odkaz:
https://doaj.org/article/7b3b5e7a5cf84a85821a46792f3aa6d7
Autor:
Takayuki Miyai, Shungo Imai, Hitoshi Kashiwagi, Yuki Sato, Shota Kadomura, Kenji Yoshida, Eri Yoshimura, Toshiaki Teraya, Takashi Tsujimoto, Yukari Kawamoto, Tatsuya Itoh, Hidefumi Ueno, Yoshikazu Goto, Yoh Takekuma, Mitsuru Sugawara
Publikováno v:
Antibiotics, Vol 9, Iss 12, p 920 (2020)
We previously constructed a risk prediction model of vancomycin (VCM)-associated nephrotoxicity for use when performing initial therapeutic drug monitoring (TDM), using decision tree analysis. However, we could not build a model to be used at the tim
Externí odkaz:
https://doaj.org/article/4ccbbef038f44dcaa273b4f55a166dc8
Autor:
Yuki Sato, Shungo Imai, Hitoshi Kashiwagi, Mitsuru Sugawara, Kenji Momo, Yoh Takekuma, Shota Kadomura, Tatsuya Itoh
Publikováno v:
Journal of Oncology Pharmacy Practice. 28:1534-1542
Introduction Delayed methotrexate (MTX) clearance with the co-administration of piperacillin/tazobactam (PIPC/TAZ) has been reported. Penicillins have been associated with reduced MTX clearance but the evidence is limited. There are no cases describe
Autor:
Hideki Matsumura, Tatsuya Itoh
Publikováno v:
SAE Technical Paper Series.
Autor:
Takayuki Nobuoka, Nobuyoshi Kawaharada, Masafumi Imamura, Takeshi Murakami, Tatsuya Itoh, Shigenori Oota, Hiroshi Yamaguchi, Minoru Nagayama, Yasutoshi Kimura, Ichiro Takemasa, Yosuke Kuroda
Publikováno v:
Langenbeck's Archives of Surgery. 405:1051-1059
Extended pancreatectomy for locally advanced pancreatobiliary malignancy often involves combined major arterial resection (AR) and reconstruction (ARc). By limiting candidate inflow for ARc after combined resection of the celiac arterial system over
Autor:
Shota Kadomura, Hitoshi Kashiwagi, Mitsuru Sugawara, Yoh Takekuma, Kotaro Kawamoto, Tatsuya Itoh, Shungo Imai
Publikováno v:
BPB Reports. 3:65-69
Autor:
Takatoshi Yotsuyanagi, Masafumi Imamura, Ichiro Takemasa, Yasutoshi Kimura, Tatsuya Itoh, Nobuyoshi Kawaharada
Publikováno v:
International Journal of Surgery Case Reports
Highlights • Transection of the celiac artery is often not justified in pancreaticoduodenectomy. • Reconstruction of the splenic and hepatic arteries might resolve this situation. • Great saphenous vein graft may be a conduit for non-anatomical
Autor:
Eri Yoshimura, Yukari Kawamoto, Yoh Takekuma, Takashi Tsujimoto, Toshiaki Teraya, Yuki Sato, Mitsuru Sugawara, Hidefumi Ueno, Shungo Imai, Tatsuya Itoh, Shota Kadomura, Kenji Yoshida, Hitoshi Kashiwagi, Takayuki Miyai, Yoshikazu Goto
Publikováno v:
Antibiotics
Antibiotics, Vol 9, Iss 920, p 920 (2020)
Volume 9
Issue 12
Antibiotics, Vol 9, Iss 920, p 920 (2020)
Volume 9
Issue 12
We previously constructed a risk prediction model of vancomycin (VCM)-associated nephrotoxicity for use when performing initial therapeutic drug monitoring (TDM), using decision tree analysis. However, we could not build a model to be used at the tim
Autor:
Tatsuya Itoh, Tadashi Hasegawa, Yasutoshi Kimura, Junji Kato, Koichi Hirata, Masafumi Imamura
Publikováno v:
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 76:1553-1561
Autor:
Masato Sumi, Yoh Takekuma, Shota Kadomura, Kotaro Kawamoto, Tatsuya Itoh, Mitsuru Sugawara, Yuki Sato
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences
Journal of Pharmaceutical Health Care and Sciences, Vol 5, Iss 1, Pp 1-8 (2019)
Journal of Pharmaceutical Health Care and Sciences, Vol 5, Iss 1, Pp 1-8 (2019)
Background Piperacillin/tazobactam (PIPC/TAZ) and cefepime (CFPM) are commonly used for the treatment of nosocomial and healthcare-associated infections. Recent reports have suggested that the incidence of acute kidney injury (AKI) in patients treate